Advertisement

Topics

#news #biotech Back-to-back FDA rejections leave Vernalis reeling

07:56 EDT 7 Aug 2017 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Back-to-back FDA rejections leave Vernalis reeling .The FDA has rejected Vernalis’ filing for approval of CCP-08. Vernalis wanted to bring CCP-08 and CCP-07 to market in time for … Continue reading

Cet article #news #biotech Back-to-back FDA rejections leave Vernalis reeling est apparu en premier sur Biotech 365.

Original Article: #news #biotech Back-to-back FDA rejections leave Vernalis reeling

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Back-to-back FDA rejections leave Vernalis reeling"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...